Internal Medicine, Cardiovascular Disease · Wichita, KS
NPI
1164493201
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
925 N Hillside St
Wichita, KS, 67214
Phone (316) 616-3333
Groups this clinician bills Medicare through
Medicare paid, 2024
$908K
21,810 services
Medicare patients, 2024
2,888
Average age 77
Drug cost, 2024
$5.1M
24,968 prescriptions
Company payments, 2025
$3,052
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hossein Amirani was code J0153 (injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)), 5,767 times for 94 patients. In total Hossein Amirani billed 21,810 services in 115 codes, and Medicare paid $908K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-11.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0153 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | Office | 5,767 | 94 | $0.39 | $2,274 |
| 99213 Office E&M - Established | Office | 1,781 | 1,456 | $51.33 | $91K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 1,296 | 647 | $86.73 | $112K |
| 93000 Electrocardiogram | Office | 1,277 | 1,087 | $8.39 | $11K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,276 | 318 | $5.46 | $6,971 |
| 99214 Office E&M - Established | Office | 1,255 | 909 | $77.31 | $97K |
| 93306 Echocardiography (TTE/TEE) | Office | 861 | 840 | $109.75 | $94K |
| 93296 External Electrocardiographic Monitoring | Office | 693 | 213 | $11.78 | $8,165 |
| 93306 Echocardiography (TTE/TEE) | Facility | 682 | 666 | $43.82 | $30K |
| 78452 Myocardial Perfusion Scan | Office | 653 | 652 | $263.54 | $172K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 652 | 651 | $0.52 | $338 |
| 93015 Electrocardiogram | Office | 636 | 635 | $41.49 | $26K |
| 93294 External Electrocardiographic Monitoring | Office | 539 | 165 | $16.36 | $8,820 |
| 93297 External Electrocardiographic Monitoring | Office | 321 | 34 | $36.02 | $12K |
| 99152 Anesthesia | Facility | 311 | 269 | $8.00 | $2,488 |
By year: 2022 $1.5M for 39,566 services; 2023 $1.4M for 37,698 services; 2024 $908K for 21,810 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85018 Blood Count | 27 | 24 | $2.15 | $58 |
| 84520 Clinical Chemistry | 23 | 21 | $3.53 | $81.27 |
| 84132 Clinical Chemistry | 22 | 20 | $4.24 | $93.2 |
| 82575 Clinical Chemistry | 20 | 19 | $8.34 | $167 |
| 82565 Clinical Chemistry | 19 | 18 | $4.76 | $90.36 |
| 80048 Clinical Chemistry | 12 | 12 | $7.60 | $91.19 |
Medicare prescription drug claims, 2024
In 2024, the drug Hossein Amirani prescribed most often to Medicare patients was Eliquis (Apixaban), with 2,455 prescriptions and refills. In total Hossein Amirani wrote 24,968 Medicare prescriptions that cost $5.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 2,455 | 3,388 | 396 | $1.9M |
| Atorvastatin Calcium Generic | 2,389 | 4,803 | 548 | $13K |
| Metoprolol Tartrate Generic | 1,857 | 3,573 | 436 | $6,463 |
| Xarelto Rivaroxaban | 1,261 | 2,213 | 248 | $1.2M |
| Carvedilol Generic | 1,160 | 2,181 | 262 | $5,259 |
| Furosemide Generic | 1,053 | 2,000 | 288 | $3,583 |
| Amlodipine Besylate Generic | 1,020 | 2,112 | 269 | $4,120 |
| Losartan Potassium Generic | 861 | 1,887 | 220 | $4,307 |
| Lisinopril Generic | 839 | 1,837 | 214 | $3,188 |
| Ezetimibe Generic | 832 | 1,485 | 178 | $11K |
| Potassium Chloride Generic | 752 | 1,315 | 177 | $10K |
| Clopidogrel Clopidogrel Bisulfate | 730 | 1,426 | 186 | $4,474 |
| Metoprolol Succinate Generic | 632 | 1,306 | 157 | $5,433 |
| Flecainide Acetate Generic | 602 | 1,176 | 123 | $11K |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 581 | 1,062 | 154 | $3,954 |
Brand drugs: 6,139 claims; generic drugs: 18,829 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hossein Amirani $3,052 ($3,052 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbott Laboratories with $1,742.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 17 | $1,742 |
| Organogenesis Inc. ORGO | 8 | $488 |
| Medtronic, Inc. MDT | 2 | $243 |
| Intuitive Surgical, Inc. ISRG | 1 | $118 |
| Novo Nordisk Inc NVO | 5 | $103 |
| Kestra Medical Technology Services, Inc. | 3 | $62.21 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $52.65 |
| Amgen Inc. AMGN | 3 | $49.72 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $39.35 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $34.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.